GLOBAL X GENOMICS & BIOTECHNOLOGY UCITS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.9 USD | +1.46% |
|
-0.43% | -17.24% |
| Current month | -14.65% | ||
| 1 month | -12.94% |
Investment objective
The Fund?s investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the ?Index?).
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 53.91 USD | +0.34% | -2.07% | -13.88% | 6.73% | ||
| 91.66 USD | +0.42% | +7.48% | +46.33% | 5.51% | ||
| 44.24 USD | +0.89% | +4.41% | -7.49% | 4.73% | ||
| 22.12 USD | +1.14% | -0.94% | -27.71% | 4.14% | ||
| 137.7 USD | +1.00% | +3.77% | -0.93% | 4.02% | ||
| 128.8 USD | +1.08% | +11.37% | +33.54% | 4.01% | ||
| 21.38 USD | -1.02% | -10.54% | -21.45% | 3.98% | ||
| 108 USD | +1.69% | +6.47% | +8.57% | 3.94% | ||
| 21.98 USD | -0.54% | -3.60% | -26.66% | 3.83% | ||
| 27.59 USD | +2.57% | -1.25% | -50.70% | 3.82% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 6.9 | +1.46% | 139 |
| 25/24/25 | 6.8 | -3.09% | 0 |
| 24/24/24 | 7.016 | -2.12% | 725 |
| 23/24/23 | 7.168 | +4.50% | 100 |
| 22/24/22 | 6.86 | +0.16% | 1,893 |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 09:05 pm IST
More quotesDescription
| IE00BM8R0N95 | |
|---|---|
| Total Expense Ratio | 0.50% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Genomics v2 Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
04/11/2021
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 28/03/2024 )
| AuM (EUR) | 7 M€ |
|---|---|
| AuM 1M | 8 M€ |
| AuM 3 months | 6 M€ |
| AuM 6 months | 5 M€ |
| AuM 12 months | 6 M€ |
- Stock Market
- ETF
- GNOG ETF
